Cassava Sciences | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
Abbott USD 40.03B 468M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Biogen USD 16.72B 357.1M 2024-12
Cassava Sciences USD 145.7M 20.94M 2024-12
Eisai JPY 873.36B 53.3B 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Geron USD 280.32M 11.96M 2024-12
J&J USD 71.49B 1.33B 2024-12
Merck USD 46.31B 1.81B 2024-12
Novartis USD 44.05B 605M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12



Cassava Sciences Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.